A subsidiary of Japanese-based Fujifilm Corp. plans to expand further a massive biopharmaceutical manufacturing plant in the state, even as the initial phase is yet complete
RALEIGH, N.C. — Hours before the Japanese prime minister's arrival in North Carolina, a subsidiary of Japan's Fujifilm Corp. announced Thursday plans to expand further a massive biopharmaceutical manufacturing plant in the state, even as the initial phase is not yet complete, promising another 680 jobs.
Gov. Roy Cooper joined a company executive and local government leaders in unveiling an additional $1.2 billion investment in Holly Springs, where Fujifilm Diosynth Biotechnologies is currently building what is billed as one of the world's largest cell culture facilities. The new jobs are on top of the 725 announced by the subsidiary when the initial $2 billion investment was announced in March 2021.
The first phase of the plant is expected to open next year, with the expansion coming online early in 2028, Lars Petersen, the subsidiary's president and CEO, told reporters. The batch of jobs announced Thursday will be created starting in 2027 and pay an average minimum wage of nearly $110,000, according to state officials.
Fujifilm Diosynth Biotechnologies, which manufactures drugs and vaccines for other pharmaceutical companies, already has a campus in nearby Research Triangle Park where it employs several hundred people.
Cooper said the expansion is the result of the state's commitment to become the nation's leader in life sciences, which he says statewide includes over 800 companies employing over 75,000 skilled workers.
“It’s pretty clear that North Carolina has become an advanced manufacturing powerhouse,” Cooper said at the announcement in
Read more on abcnews.go.com